T1	missed_chemical 193622 193625	PLP
T2	missed_chemical 193630 193633	DOX
T3	disease_or_phenotypic_feature 193637 193645	melanoma
T4	disease_or_phenotypic_feature 193719 193724	tumor
T5	chemical 193741 193750	oxidative
T6	disease_or_phenotypic_feature 193891 193894	RAd
T7	disease_or_phenotypic_feature 193903 193916	cerviX cancer
T8	chemical 194001 194008	radical
T9	disease_or_phenotypic_feature 194269 194272	CSP
T10	chemical 194326 194332	sodium
T11	chemical 194344 194390	tetrakis[3,5-bis(trifluoromethyl)phenyl]borate
T12	chemical 194344 194396	tetrakis[3,5-bis(trifluoromethyl)phenyl]borate salts
T13	chemical 194461 194479	[hexane-2-propanol
T14	chemical 194511 194519	Paraquat
T15	disease_or_phenotypic_feature 194524 194543	Parkinson's disease
T16	chemical 194672 194682	inhibitors
T17	chemical 194744 194758	drug-resistant
T18	disease_or_phenotypic_feature 194759 194770	influenza A
T19	disease_or_phenotypic_feature 194791 194800	influenza
T20	disease_or_phenotypic_feature 194829 194847	influenza-infected
T21	chemical 194871 194880	Chalcones
T22	chemical 194911 194915	drug
T23	disease_or_phenotypic_feature 194956 194963	malaria
T24	chemical 195026 195036	biomarkers
T25	disease_or_phenotypic_feature 195105 195119	Chagas disease
T26	chemical 195187 195191	mRNA
T27	chemical 195196 195203	protein
T28	disease_or_phenotypic_feature 195301 195307	injury
T29	chemical 195415 195425	eplerenone
T30	corrected_disease_or_phenotypic_feature 195443 195483	chronic central serous chorioretinopathy
T31	disease_or_phenotypic_feature 195451 195483	central serous chorioretinopathy
T32	chemical 195550 195554	CGRP
T33	disease_or_phenotypic_feature 195587 195595	Migraine
T34	chemical 195737 195747	biomarkers
T35	disease_or_phenotypic_feature 195791 195804	breast cancer
T36	chemical 195931 195937	oxygen
T37	disease_or_phenotypic_feature 195968 195991	obstructive sleep apnea
T38	chemical 196040 196043	NPC
T39	disease_or_phenotypic_feature 196040 196043	NPC
T40	chemical 196168 196171	RNA
T41	disease_or_phenotypic_feature 196230 196241	sensitivity
T42	chemical 196332 196340	Nanorods
T43	chemical 196362 196371	Porphyrin
T44	disease_or_phenotypic_feature 196436 196446	Anti-tumor
T45	chemical 196539 196555	dabrafenib-based
T46	disease_or_phenotypic_feature 196573 196581	melanoma
T47	chemical 196634 196641	retinal
T48	chemical 196642 196652	biomarkers
T49	chemical 196686 196695	retinitis
T50	disease_or_phenotypic_feature 196686 196706	retinitis pigmentosa
T51	disease_or_phenotypic_feature 196884 196889	tumor
T52	disease_or_phenotypic_feature 196928 196933	tumor
T53	chemical 196960 196976	immunomodulation
T54	chemical 196981 196985	drug
T55	chemical 197084 197097	antibody-drug
T56	disease_or_phenotypic_feature 197141 197163	acute myeloid leukemia
T57	disease_or_phenotypic_feature 197165 197169	AML)
T58	corrected_chemical 197234 197257	Topical Corticosteroids
T59	chemical 197242 197257	Corticosteroids
T60	corrected_disease_or_phenotypic_feature 197286 197313	Childhood Atopic Dermatitis
T61	disease_or_phenotypic_feature 197296 197313	Atopic Dermatitis
R1	treats Arg1:T36 Arg2:T37
R2	treats Arg1:T21 Arg2:T23
R3	treats Arg1:T1 Arg2:T4
R4	treats Arg1:T1 Arg2:T3
R5	treats Arg1:T58 Arg2:T60
R6	treats Arg1:T29 Arg2:T30
R7	treats Arg1:T22 Arg2:T23
R8	treats Arg1:T2 Arg2:T3
R9	treats Arg1:T2 Arg2:T4
R10	treats Arg1:T54 Arg2:T51
